Alembic gets final approval for Binimetinib
Alembic Pharmaceuticals Limited (NSE: APLLTD) has received final USFDA approval for generic Binimetinib tablets in 15 mg and 45 mg strengths. The product has an estimated US reference market of US$282 million for the 12 months ended Septem…



















